BEGIN:VCALENDAR VERSION:2.0 PRODID:IEEE vTools.Events//EN CALSCALE:GREGORIAN BEGIN:VTIMEZONE TZID:Canada/Eastern BEGIN:DAYLIGHT DTSTART:20220313T030000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3 TZNAME:EDT END:DAYLIGHT BEGIN:STANDARD DTSTART:20211107T010000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11 TZNAME:EST END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTAMP:20211215T162141Z UID:F2CBD9A7-0FD8-425E-95E1-ABFD8FA7887E DTSTART;TZID=Canada/Eastern:20211203T100000 DTEND;TZID=Canada/Eastern:20211203T110000 DESCRIPTION:Mesure de SpO2 et au-delà: importance de l'oxymétrie dans le système de santé actuel en pleine évolution\n\nFrançois LELLOUCHE\, MD \, PhD\, Institut universitaire de cardiologie et de pneumologie de Québe c et professeur au Département de médecine de l'Université Laval\n\nVen dredi le 3 décembre 2021 à 10h00\, en direct sur Zoom / Friday December 3\, 2021 at 10 am on Zoom :\n\nhttps://us02web.zoom.us/j/88963498537?pwd=b 1lxUGpFRTRtNlVRUkFVZnc2U2wrUT09\n\nRésumé : La mesure de l'oxymétrie pu lsée ou SpO2 (5ème signe vital) représente un enjeu majeur pour le syst ème de santé. Les questions reliées à l'oxymétrie vont au-delà de la fiabilité de la mesure de la SpO2 (question non encore résolue) et des nombreuses valeurs dérivées qui peuvent être mesurées avec le même ca pteur. Nous discuterons des autres enjeux reliés aux nouvelles recommanda tions pour administrer et surveiller précisément l'oxygène\, aux métho des innovantes d'administrations de l'oxygénothérapie et autres stratég ies de prise en charge des patients sous oxygène en ambulatoire.\n\nFran çois LELLOUCHE\, MD\, PhD obtained the MD degree in internal medicine in 2001 and critical care medicine in 2004 from the Pierre et Marie Curie Uni versity (Paris VI) and the PhD degree in Science and Engineering: Material s - Modeling - Environment\, University of Paris XII\, with Pr Laurent Bro chard as supervisor. He was an INSERM – CIHR Postdoctoral Fellow at the Saint-Michael hospital laboratory (Pr Sinderby and Arthur Slutsky). He is currently critical care physician at the Quebec Heart and Lung University Institute and Associate Professor at the Department of medicine at Laval U niversity. His research interests include humidification of gas during mec hanical ventilation\, noninvasive mechanical ventilation\, high flow oxyge n therapy and new modes of mechanical ventilation\, focusing on automated modes of respiratory support and closed-loop oxygen supplementation. He co nducts at the research center of the Quebec Heart and Lung Institute bench studies\, physiological studies focusing on breathing physiology and clin ical trials to evaluate the clinical impact based on preliminary studies. His laboratory develops several innovative devices in the field of respira tory and oxygen support\, including the FreeO2 device\, a new breakthrough closed loop device that titrates oxygen flow based on patient’ needs. H e co-founded with Pr Erwan L’Her the Oxynov company that manufactures an d commercializes the FreeO2 device in Europe\, Asia and Canada. He develop ed the “VentilO” application to promote lung protective ventilation an d explain the relations between tidal volume\, respiratory rate and dead s pace. He is currently PI of several studies focusing on COVID-19 managemen t including a CIHR funded multicentric study on automated oxygen titration to reduce healthcare workers interventions and a pilot study on new COVID treatments.\n\nSpeaker(s): Dr François Lellouche\, \n\nVirtual: https:// events.vtools.ieee.org/m/291910 LOCATION:Virtual: https://events.vtools.ieee.org/m/291910 ORGANIZER:benoit.gosselin@gel.ulaval.ca SEQUENCE:1 SUMMARY:Séminaires virtuels du CHAPITRE EMBS/CASS de Québec URL;VALUE=URI:https://events.vtools.ieee.org/m/291910 X-ALT-DESC:Description: <br /><p><span style="font-size: 18pt\;"><strong>Me sure de SpO2 et au-del&agrave\;: importance de l'oxym&eacute\;trie dans le syst&egrave\;me de sant&eacute\; actuel en pleine &eacute\;volution</stro ng></span></p>\n<p><strong>Fran&ccedil\;ois LELLOUCHE\, MD\, PhD</strong>< strong>\, </strong><strong>Institut universitaire de cardiologie et de pne umologie de Qu&eacute\;bec et professeur au D&eacute\;partement de m&eacut e\;decine de l'Universit&eacute\; Laval</strong></p>\n<p><strong>Vendredi le 3 d&eacute\;cembre 2021 &agrave\; 10h00\,&nbsp\;en direct sur Zoom&nbsp \;/ Friday December 3\, 2021 at 10 am on Zoom&nbsp\;:</strong></p>\n<p><a href="https://us02web.zoom.us/j/88963498537?pwd=b1lxUGpFRTRtNlVRUkFVZnc2U2 wrUT09">https://us02web.zoom.us/j/88963498537?pwd=b1lxUGpFRTRtNlVRUkFVZnc2 U2wrUT09</a></p>\n<p><strong>R&eacute\;sum&eacute\; : </strong>La mesure d e l'oxym&eacute\;trie puls&eacute\;e ou SpO2 (5&egrave\;me signe vital) re pr&eacute\;sente un enjeu majeur pour le syst&egrave\;me de sant&eacute\;. Les questions reli&eacute\;es &agrave\; l'oxym&eacute\;trie vont au-del&a grave\; de la fiabilit&eacute\; de la mesure de la SpO2 (question non enco re r&eacute\;solue) et des nombreuses valeurs d&eacute\;riv&eacute\;es qui peuvent &ecirc\;tre mesur&eacute\;es avec le m&ecirc\;me capteur. Nous di scuterons des autres enjeux reli&eacute\;s aux nouvelles recommandations p our administrer et surveiller pr&eacute\;cis&eacute\;ment l'oxyg&egrave\;n e\, aux m&eacute\;thodes innovantes d'administrations de l'oxyg&eacute\;no th&eacute\;rapie et autres strat&eacute\;gies de prise en charge des patie nts sous oxyg&egrave\;ne en ambulatoire.</p>\n<p><strong style="caret-colo r: #000000\; color: #000000\; font-family: Calibri\, sans-serif\; font-siz e: 14.666666984558105px\; font-style: normal\; font-variant-caps: normal\; letter-spacing: normal\; orphans: auto\; text-align: start\; text-indent: 0px\; text-transform: none\; white-space: normal\; widows: auto\; word-sp acing: 0px\; -webkit-text-size-adjust: auto\; -webkit-text-stroke-width: 0 px\; text-decoration: none\;">Fran&ccedil\;ois LELLOUCHE\, MD\, PhD</stron g><span style="caret-color: #000000\; color: #000000\; font-family: Calibr i\, sans-serif\; font-size: 14.666666984558105px\; font-style: normal\; fo nt-variant-caps: normal\; font-weight: normal\; letter-spacing: normal\; o rphans: auto\; text-align: start\; text-indent: 0px\; text-transform: none \; white-space: normal\; widows: auto\; word-spacing: 0px\; -webkit-text-s ize-adjust: auto\; -webkit-text-stroke-width: 0px\; text-decoration: none\ ; display: inline !important\; float: none\;"> obtained the MD degree in i nternal medicine in 2001 and critical care medicine in 2004 from the Pierr e et Marie Curie University (Paris VI) and the PhD degree in Science and E ngineering: Materials - Modeling - Environment\, University of Paris XII\, with Pr Laurent Brochard as supervisor. He was an INSERM &ndash\; CIHR Po stdoctoral Fellow at the Saint-Michael hospital laboratory (Pr Sinderby an d Arthur Slutsky). He is currently critical care physician at the Quebec H eart and Lung University Institute and Associate Professor at the Departme nt of medicine at Laval University. His research interests include humidif ication of gas during mechanical ventilation\, noninvasive mechanical vent ilation\, high flow oxygen therapy and new modes of mechanical ventilation \, focusing on automated modes of respiratory support and closed-loop oxyg en supplementation. He conducts at the research center of the Quebec Heart and Lung Institute bench studies\, physiological studies focusing on brea thing physiology and clinical trials to evaluate the clinical impact based on preliminary studies. His laboratory develops several innovative device s in the field of respiratory and oxygen support\, including the FreeO</sp an><sub style="caret-color: #000000\; color: #000000\; font-family: Calibr i\, sans-serif\; font-style: normal\; font-variant-caps: normal\; font-wei ght: normal\; letter-spacing: normal\; orphans: auto\; text-align: start\; text-indent: 0px\; text-transform: none\; white-space: normal\; widows: a uto\; word-spacing: 0px\; -webkit-text-size-adjust: auto\; -webkit-text-st roke-width: 0px\; text-decoration: none\;">2</sub><span style="caret-color : #000000\; color: #000000\; font-family: Calibri\, sans-serif\; font-size : 14.666666984558105px\; font-style: normal\; font-variant-caps: normal\; font-weight: normal\; letter-spacing: normal\; orphans: auto\; text-align: start\; text-indent: 0px\; text-transform: none\; white-space: normal\; w idows: auto\; word-spacing: 0px\; -webkit-text-size-adjust: auto\; -webkit -text-stroke-width: 0px\; text-decoration: none\; display: inline !importa nt\; float: none\;"> device\, a new breakthrough closed loop device that t itrates oxygen flow based on patient&rsquo\; needs. He co-founded with Pr Erwan L&rsquo\;Her the Oxynov company that manufactures and commercializes the FreeO</span><sub style="caret-color: #000000\; color: #000000\; font- family: Calibri\, sans-serif\; font-style: normal\; font-variant-caps: nor mal\; font-weight: normal\; letter-spacing: normal\; orphans: auto\; text- align: start\; text-indent: 0px\; text-transform: none\; white-space: norm al\; widows: auto\; word-spacing: 0px\; -webkit-text-size-adjust: auto\; - webkit-text-stroke-width: 0px\; text-decoration: none\;">2</sub><span styl e="caret-color: #000000\; color: #000000\; font-family: Calibri\, sans-ser if\; font-size: 14.666666984558105px\; font-style: normal\; font-variant-c aps: normal\; font-weight: normal\; letter-spacing: normal\; orphans: auto \; text-align: start\; text-indent: 0px\; text-transform: none\; white-spa ce: normal\; widows: auto\; word-spacing: 0px\; -webkit-text-size-adjust: auto\; -webkit-text-stroke-width: 0px\; text-decoration: none\; display: i nline !important\; float: none\;"> device in Europe\, Asia and Canada. He developed the &ldquo\;VentilO&rdquo\; application to promote lung protecti ve ventilation and explain the relations between tidal volume\, respirator y rate and dead space. He is currently PI of several studies focusing on C OVID-19 management including a CIHR funded multicentric study on automated oxygen titration to reduce healthcare workers interventions and a pilot s tudy on new COVID treatments.</span></p> END:VEVENT END:VCALENDAR